Navigation Links
Indian Boffins to Fight Wrinkles With Camels' Milk

Indian scientists are hoping to turn camels' milk into a skin-care product that would wipe away wrinkles and lighten the complexion, a report said Monday .

The government's team of camel researchers, which has already pioneered such products as camel milk ice cream, said it has found cosmetic properties in the hardy mammal's milk.

"The cream developed from camel milk has been given to a hospital's skin department to study it on 20 people for at least four months," centre director K.M.L. Pathak told the United News of India agency.

"Only after laboratory experiments and tests would the cream be produced commercially," said the chief scientist of the unit, which is based in the desert state of Rajasthan and has bred a herd of 270 camels for research projects.

Having fairer skin is something of a national obsession in India and has helped spur massive growth in the beauty industry, currently worth around 180 billion rupees (400 million dollars) annually.


'"/>




Page: 1

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
(Date:7/18/2008)...wswire/ -- In the last ten years over 360,children... average of 36,per year, according to a study by M...ces., (See video from General Motors (NYSE: GM...y=35362 ) Hyperthermia is the overheating of the ...s a car can become for a small child in just a few...
(Date:7/18/2008)...uly 18 /PRNewswire-USNewswire/ -- Two consumer,gro...controversial patent,on human embryonic stem cells...(WARF)., Consumer Watchdog, formerly The Foundati...c Patent Foundation appealed to the U.S. Patent,Of... examiner narrowed,WARF,s patent after the two gro...
(Date:7/18/2008)... New research led by a Michigan State University ...rweight workers are lazier, more emotionally unsta...l weight" colleagues. , With the findings, emplo...based stereotypes when it comes to hiring, promoti...or of human resource management, and two colleague...
(Date:7/18/2008)...Newswire/ -- Highmark Blue Cross Blue Shield,Unit...s will join forces to,promote healthy smiles and l...and continuing until 3 p.m., tomorrow, July 19, a ...al screenings, restorations and sealants,for those...ived much less attention in,American culture than ...
Breaking Medicine News(10 mins):Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:Studies refute common stereotypes about obese workers 2Health News:Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday 2
...students gathered for a live chat with Indian Amer...xciting to view her as she spoke from her zero-gra...ds and necklace floating loosely, a scientific fac...fore. It was equally thrilling to be able to see ...
...en have you relied on your instincts or ‘gut-feel’...about time you do, because a recent study has rein...reliable beacon. A study conducted by the Unive...e in the journal, Current Biology, has shown the w...
...be still far from reality, but the very idea is bo...d the possibility of administering insulin orally/...sulin is given via injections or via inhalation li...ists from Taiwan’s National Tsing Hua University h...
...ton – The last ten years have witnessed a surge in...rtray//. The data shows that the number of surger... 64 age group and by 726 percent among patients be...res which are clubbed under the technical name, ba...
Other Medicine News:Health News:Indian Students Thrilled to Talk to Sunita Williams 2
(Date:7/16/2008)...ly 17 /- Vical Incorporated...ith preliminary clinical,trial data demonstrating ...mmune responses against H5N1 pandemic influenza in...from conventional vaccines because they do not,con...ompelling advantages,in response to a pandemic out...
(Date:7/16/2008)...n rank discomfort as #1 reason to avoid discussing...rt disease, INDIANAPOLIS, July 16 /PRNewswire-Fir...ent of men with erectile dysfunction (ED) surveyed...itions, such as heart,disease and diabetes, nearly...h their doctors. The survey, conducted by Ipsos Pu...
(Date:7/15/2008)...July 15 /- Abeome Corporation, a,Geor...egic equity,investment by Cato BioVentures and a c...ontract research and development organization. The...ntinued development of Abeome,s lead,ovarian cance...y improves the development of,monoclonal antibodie...
(Date:7/15/2008)...., July 15 /- Alfacell Corp...as entered into a distribution,agreement with Mega...rael,for the commercialization of ONCONASE(R) (ra...drug candidate, recently completed an internationa...ectable malignant,mesothelioma (UMM)., Under the ...
Breaking Medicine Technology:Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 2Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 3Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 4Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 5Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data 6The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 2Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 3Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel 4Invest in a future without dementia 22165 1Invest in a future without dementia 22165 2Sprinters closest to starter pistol have advantage over those farther away says study 22163 1Sprinters closest to starter pistol have advantage over those farther away says study 22163 2Bar Drinks Pack More Punch Than Thought 22161 1Bar Drinks Pack More Punch Than Thought 22161 2Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference 22159 1Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference 22159 2
...RANCISCO, May 07, 2007 /PRNewswire/ -- Interim res...l kidney-sparing treatment,protocol using CellCept...American Transplant Congress. This and other Spare...splant recipients,examine ways to prevent rejectio...ts are living longer, doctors are finding,that old...
...E, Calif., May 08, 2007 /PRNewswire-FirstCall/ -- ...s from the preliminary,analysis of its U.S. Phase ...ment of allergic conjunctivitis. The study evaluat...nce daily and twice,daily. The primary endpoints o...potastine in treating ocular itching and redness.,...
Other Medicine Technology:Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 2Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 3Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 4Early Results of the CellCept Spare the Nephron Study Examine,Kidney Function 5ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 2ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 3ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 4ISTA Pharmaceuticals Announces Statistically Significant,Preliminary Results From its U.S. Phase II/III Clinical Study Of,Bepotastine 5
Each handle is designed to fit a specific trephine size.
Each handle is designed to fit a specific trephine size.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons.
Medicine Products: